MIM
MRNA icon

Macroview Investment Management’s Moderna MRNA Stock Holding History

Macroview Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55
Closed -$6.53K – 617
2024
Q2 		$6.53K Buy
+55
New +$6.96K 0.01% 337
2023
Q4 		– Sell
-75
Closed -$7.75K – 764
2023
Q3 		$7.75K Buy
+75
New +$8.37K 0.01% 311
2022
Q3 		– Sell
-7
Closed -$1K – 476
2022
Q2 		$1K Hold
7
– – ﹤0.01% 403
2022
Q1 		$1K Hold
7
– – ﹤0.01% 390
2021
Q4 		$2K Sell
7
-24
-77% -$7.02K ﹤0.01% 328
2021
Q3 		$12K Buy
+31
New +$11.4K 0.02% 154

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macroview Investment Management's MRNA Position: Q3 2024 in Review

Macroview Investment Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 55 shares — an estimated $6.53K sold.

Macroview Investment Management first reported a position in MRNA in Q3 2021 and held it in 6 quarters. The position peaked at $12K in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Macroview Investment Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Macroview Investment Management sold 55 Moderna shares in Q3 2024, an estimated $6.53K.
  • Macroview Investment Management first reported a position in Moderna in Q3 2021 and held it in 6 quarters.
  • Macroview Investment Management's Moderna position peaked at $12K in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Macroview Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.